A while ago I wrote about a new medical drug to produce darker, thicker, longer eyelashes.
Allergan, the maker of Botox, hopes to launch this new cosmetic drug next summer. The active ingredient is bimatoprost, which is Allergan’s glaucoma drug, Lumigen.
David Pyott, Chairman of Allergan, feels sales from this product could exceed $500 million. There will be a lot of long lashes.
The drug will be applied in much the same way as a woman applies eyeliner. Allegan recently filed a lawsuit against Jan Marini Skin Research for infringing on Allergan’s patent rights to the use of prostaglandins to enhance eyelash growth.
Jan Marini took their product off the market but in response they said they are coming out with an eyelash enhancer that is “non-prostaglandin” and works as well or better than Allergan’s.
Let the battle begin.
For more information on all manner of cosmetic surgery and plastic surgery subjects, visit Dr. Brueck's web site at http://www.Beauty-by-Brueck.com
Thanks for the info Dr Brueck... Have been getting Jan Marini's side of the story in all my trade mags. In fact two other companies have product launches, which state wonderful results "without the bad stuff" .
ReplyDeleteIt seems there have been alto of complications and side effects as well,,,
Count me out on this one, till the battle dust settles more